ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00035789
Recruitment Status : Completed
First Posted : May 6, 2002
Last Update Posted : April 14, 2011
Sponsor:
Information provided by:
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2005
  Actual Study Completion Date : May 2005
  Certification/Extension First Submitted : January 28, 2010